FFA
RCUS icon

Farther Finance Advisors’s Arcus Biosciences RCUS Stock Holding History

Farther Finance Advisors’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.62K Buy
179
+41
+30% +$1.16K ﹤0.01% 5051
2026
Q2 		$4.26K Sell
138
-25
-15% -$618 ﹤0.01% 4882
2026
Q1 		$3.56K Sell
163
-17
-9% -$367 ﹤0.01% 4666
2025
Q4 		$4.29K Buy
180
+9
+5% +$184 ﹤0.01% 4391
2025
Q3 		$2.33K Buy
+171
New +$1.78K ﹤0.01% 4081
2025
Q1 		– Sell
-1
Closed -$15 – 4393
2024
Q4 		$15 Hold
1
– – ﹤0.01% 3952
2024
Q3 		$15 Buy
+1
New +$16 ﹤0.01% 3936
2024
Q1 		– Sell
-1
Closed -$19 – 3713
2023
Q4 		$19 Buy
+1
New +$16 ﹤0.01% 3466

Other funds holding RCUS

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
DCM
Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

Farther Finance Advisors's RCUS Position: Q3 2026 in Review

Farther Finance Advisors increased its Arcus Biosciences (RCUS) stake by 30% in Q3 2026, buying an estimated $1.16K and bringing the position to 179 shares worth $4.62K. The position accounts for ﹤0.01% of the portfolio, ranked #5051.

Farther Finance Advisors first reported a position in RCUS in Q4 2023 and has held it in 8 quarters since. 7 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.

  • Farther Finance Advisors held 179 shares of Arcus Biosciences worth $4.62K as of Q3 2026.
  • Farther Finance Advisors bought 41 Arcus Biosciences shares in Q3 2026, an estimated $1.16K.
  • Arcus Biosciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5051 holding.
  • Farther Finance Advisors first reported a position in Arcus Biosciences in Q4 2023 and has held it in 8 quarters since.
  • 7 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.